Wang Chang, Chen Weiwei, Yu Ming, Yang Ping
Department of Cardiology, China-Japan Union Hospital of Jilin University, Jilin Provincial Precision Medicine Key Laboratory for Cardiovascular Genetic Diagnosis, Jilin Provincial Engineering Laboratory for Endothelial Function and Genetic Diagnosis of Cardiovascular Disease, Jilin Provincial Molecular Biology Research Center for Precision Medicine of Major Cardiovascular Disease, Jilin Provincial Cardiovascular Research Institute, Changchun, Jilin 130028, P.R. China.
Exp Ther Med. 2020 Nov;20(5):42. doi: 10.3892/etm.2020.9170. Epub 2020 Sep 2.
Trans-radial access for percutaneous coronary intervention or angiography has gained popularity amongst interventional cardiologists. Radial access is also thought to reduce the incidence of acute kidney injury (AKI) in the immediate post-operative period. The purpose of the present study was to perform a comprehensive updated systematic review and meta-analysis comparing the incidence of AKI following the radial vs. femoral route of coronary catheterization. An electronic literature search of the PubMed, BioMed Central, Scopus, Cochrane Central Register of Controlled Trials and Google Scholar databases up to 1st January 2020 was performed. A total of 14 studies were included, 2 of which were randomized controlled trials (RCTs), and 6 studies utilized propensity score matching. Comparison of the data of 21,479 patients in the radial group and 25,337 patients in the femoral group indicated a reduced incidence of AKI with the radial route [odds ratio (OR):0.66, 95% CI: 0.54-0.81, P<0.0001, I=74%]. Similar results were obtained with sub-group analyses for RCTs (OR: 0.87, 95% CI: 0.77-0.98, P=0.02, I=0%), retrospective studies (OR: 0.57, 95% CI: 0.36-0.90, P=0.02, I=86%) and propensity score-matched studies (OR: 0.63, 95% CI: 0.48-0.83, P=0.0009, I=45%). Multivariable-adjusted ORs of AKI for the radial vs. femoral route were extracted from non-RCTs and pooled for a meta-analysis, which also demonstrated similar results (OR: 0.70, 95% CI: 0.57-0.88, P=0.002, I=70%). Within the limitations of the study, the present results indicate that, as compared to femoral access, the use of trans-radial access for coronary catheterization is associated with a significantly reduced incidence of AKI. A reduction of AKI by ~34% may be expected with the use of radial access.
经桡动脉途径进行经皮冠状动脉介入治疗或血管造影术在介入心脏病学家中越来越受欢迎。桡动脉途径还被认为可降低术后即刻急性肾损伤(AKI)的发生率。本研究的目的是进行一项全面的更新系统评价和荟萃分析,比较冠状动脉导管插入术经桡动脉与经股动脉途径后AKI的发生率。对截至2020年1月1日的PubMed、BioMed Central、Scopus、Cochrane对照试验中央注册库和谷歌学术数据库进行了电子文献检索。共纳入14项研究,其中2项为随机对照试验(RCT),6项研究采用倾向评分匹配。对桡动脉组的21479例患者和股动脉组的25337例患者的数据进行比较,结果显示经桡动脉途径AKI的发生率降低[优势比(OR):0.66,95%置信区间(CI):0.54 - 0.81,P < 0.0001,I = 74%]。RCT亚组分析(OR:0.87,95% CI:0.77 - 0.98,P = 0.02,I = 0%)、回顾性研究(OR:0.57,95% CI:0.36 - 0.90,P = 0.02,I = 86%)和倾向评分匹配研究(OR:0.63,95% CI:0.48 - 0.83,P = 0.0009,I = 45%)也得到了类似结果。从非RCT中提取经桡动脉与经股动脉途径AKI的多变量调整OR,并进行荟萃分析,结果也显示了类似结果(OR:0.70,95% CI:0.57 - 0.88,P = 0.002,I = 70%)。在本研究的局限性范围内,目前的结果表明,与经股动脉途径相比,冠状动脉导管插入术采用经桡动脉途径与AKI发生率显著降低相关。采用桡动脉途径预计可使AKI降低约34%。